Postnatal degeneration of photoreceptors underlies the most common causes of irreversible blindness. Rod-cone photoreceptor dystrophy is a group of congenital retinal degenerative disorders characterized by postnatal onset of progressive photoreceptor cell loss[@b1][@b2], leading to severe visual impairment and deterioration. Molecular genetic studies have revealed the underlying causes in only ∼50% of these patients. Striking characteristics of these diseases are their genetic heterogeneity and large variability in the age of onset, progression, and final visual outcome that can be found even between monozygotic twins[@b3][@b4][@b5], suggesting the impact of factors other than genetics on its pathogenesis. Contribution of epigenetically-regulated events *in utero* toward the adult onset of retinal degeneration is unclear.

Due to minimal cell turnover, the postnatal retina is particularly vulnerable to insults during embryonic development. Epigenetic events mediated by repressive histone methylation regulate the transcriptional programs in proliferating embryonic stem cells and their differentiated, post-mitotic progeny by suppressing transcription in specific fetal genes. These early developmental events may serve as a nexus point of cell proliferation and differentiation that persists into adulthood to allow establishment of stabilized expression of postnatal genes and maintain tissue homeostasis. Perturbation of this process, via inhibition of repressive histone methyltransferase (HMT) activity in embryonic retinal progenitors, may lead to disruption of postnatal homeostasis. Consequently, inhibition of repressive HMT activity could lead to postnatal retinal degeneration through "developmental reprogramming" that stems from aberrant derepression of a subset of normally silenced genes[@b6].

A candidate repressive HMT whose embryonic disruption may interfere with postnatal retinal homeostasis is *enhancer of zeste homolog 2* (*Ezh2*), the enzymatic subunit of the polycomb repressive complex 2 (PRC2). Ezh2 trimethylates histone H3 at lysine 27 (H3K27me3), a repressive histone mark that is known to persist into adulthood[@b7][@b8]. Previous reports have shown that *Ezh2*/*EZH2* is abundant during embryonic development but is absent during the late postnatal period and adulthood in mice and humans[@b9][@b10][@b11]. Conditional loss-of-function experiments in which an early (E9.5) retinal Cre driver, such *as Dkk3*-[@b12] or *Pax6-αCre*, was used to delete retinal *Ezh2,* has demonstrated a role for this HMT in the proliferation and differentiation of retinal progenitor cells (RPCs)[@b13][@b14]. To circumvent this issue and focus on a role for *Ezh2*-mediated repressive modifications in postnatal retinal homeostasis, we generated mice carrying *Ezh2* deficiency selectively in RPCs at a later time point (E11.5 and later), using *Chx10* promoter[@b15][@b16][@b17]. Here we report that *Chx10-Cre; Ezh2* deficient retinae developed normally to the perinatal period; however *Ezh2* mutant retinae underwent progressive photoreceptor degeneration postnatally, a period during which *Ezh2* is no longer expressed in wild type retinae. Taken together, these findings provide new insights into how dysregulation of *Ezh2* function in development may contribute to retinal degeneration in postnatal life.

Results
=======

*Ezh2* deficiency driven by *Chx10-Cre* induces progressive retinal degeneration in postnatal life
--------------------------------------------------------------------------------------------------

Mice with loxP sites flanking exons encoding the catalytic SET domain of *Ezh2* (*Ezh2*^*flox/flox*^) ([Fig. 1a](#f1){ref-type="fig"}) were crossed with mice expressing Cre-recombinase under the control of a bacterial artificial chromosome encoding *Chx10* (*Chx10-Cre*). The *Chx10-cre* mouse line directs high-level Cre expression after E11.5 onward in intermediate and late RPCs, which leads to retinal-specific excision in virtually all RPC-derived cells of the retina[@b16]. All mice were genotyped by PCR of tail genomic DNA for *Ezh2*^*flox/flox*^ alleles ([Fig. 1b](#f1){ref-type="fig"}). In knockout (KO or *Chx10-cre;Ezh2*^*flox/flox*^) mice, the level of *Ezh2* expression was nearly undetectable at E13 through postnatal 1 month (1 M) of age ([Fig. 1c,d](#f1){ref-type="fig"}). Consequently, *H3K27me3* deposition in retinal progenitor cells (RPCs; neuroblast layer) of KO mice was largely decreased compared to WT controls at E13.5 ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}). In contrast, *Ezh2* was detected in RPCs of the embryonic retinas of control mice (*Ezh2*^*flox/flox*^); at P0, this expression was limited to the ganglion cell layer (GCL; [Fig. 1c](#f1){ref-type="fig"}) but its expression was extinguished in the retina at 1 M ([Fig. 1c,d](#f1){ref-type="fig"}). These data confirmed that *Ezh2* was successfully deleted in the retina of KO mice.

To assess the effect of *Ezh2* deletion, we compared the morphology and numbers of retinal neurons in KO mice to control mice at different stages. KO mice exhibited largely normal structured retina at birth; however, despite the normally absent expression of *Ezh2* at 1 M, KO retina underwent progressive degeneration that gradually occurred from 1 M throughout adulthood. Consistent with the reported role of *Ezh2* in regulating RPC proliferation and retinogenesis, the retina of KO mice ([Fig. 1e,f](#f1){ref-type="fig"}) was slightly (∼20%) thinner than their littermate controls or those with heterozygous *Ezh2* deletion (*Ezh2*^+/−^ or *Chx10-cre; Ezh2*^*flox*/+^) at P0.

The thickness of the retina, especially the outer nuclear layer (ONL), continued to decrease from 1 M to 12 M ([Fig. 1g](#f1){ref-type="fig"} and [Supplementary Fig. 2](#S1){ref-type="supplementary-material"}). This was confirmed by measuring retinal thicknesses in both H&E stained retinal sections ([Supplementary Fig. 2a,b](#S1){ref-type="supplementary-material"}) and by non-invasive imaging with high-resolution spectrum domain-optic coherence topography in live animals ([Supplementary Fig. 2d,e](#S1){ref-type="supplementary-material"}). The ONL thickness of 1 M KO mice was ∼25% thinner than the control mice; by 12 M, and it was reduced to 50% of that in littermate controls. Ultrastructural analysis of photoreceptor outer segments (OS) with electron microscopy revealed less dense and sometimes disintegrated OS in 1 M KO mice, supporting the on-going photoreceptor degeneration in these mice; whereas, the retina of their littermate controls exhibited well-aligned OS discs ([Supplementary Fig. 2f](#S1){ref-type="supplementary-material"}). Moreover, electroretinography (ERG) analyses showed progressive loss of photoreceptor functions as measured by scotopic a-wave and photopic b-wave, which represent rod and cone functions, respectively. From 1 M to 12 M, the amplitudes of scotopic a-wave of KO mice reduced from 65% of that of littermate controls to 20%; scotopic ([Fig. 2e](#f2){ref-type="fig"}) and photopic (not shown) b-waves exhibited similar reduction from 1 M to 12 M ([Fig. 2](#f2){ref-type="fig"}). Less robust, but significant, loss of bipolar cells (10% at 1 M and 25% at 12 M) was also observed in KO retinae as compared with that of littermate controls ([Supplementary Fig. 3](#S1){ref-type="supplementary-material"}). No significant loss of RGCs was noted in the KO retina as compared to littermate control mice (not shown). Together, our data indicates that *Ezh2* deficiency during development results in progressive retinal, primarily photoreceptor, degeneration throughout the postnatal period.

*Ezh2* deficiency results in selective dysregulation of *Six1* and photoreceptor-related genes
----------------------------------------------------------------------------------------------

To define the genetic landscape of the KO vs control retinae, we analyzed gene transcripts in the P0 retina using Affymetrix cDNA microarray. P0 was selected because this is when *Ezh2* disappears from the outer neuroblast layer or RPCs while KO retina revealed a largely normal appearance without massive degeneration. Surprisingly, instead of finding a broad change in gene expression profiles, our comparison of over 24,000 cDNA transcripts (detected from \>28,000 transcripts being screened) of KO vs. control retinae of P0 mice revealed only 132 genes with over 1.5 fold change ([Fig. 3a](#f3){ref-type="fig"} and [Table 1](#t1){ref-type="table"}). As *Ezh2* is usually considered to deposit a repressive mark, we performed gene Ontology (GO) (<http://david.abcc.ncifcrf.gov/>) analysis[@b18][@b19] particularly for genes that were upregulated in KO mice and likely repressive targets of *Ezh2*. Remarkably, the large majority of these genes were related to photoreceptor development or function ([Fig. 3b,c](#f3){ref-type="fig"}), implicating selective and cell type-specific gene regulation or suppression in RPCs by *Ezh2*.

We did not observe changes in the expression of genes related specifically to other retinal cell types, including RPCs, RGCs, bipolar cells, and Müller cells ([Fig. 3d](#f3){ref-type="fig"}). Results of qPCR analysis in P0 retina confirmed the microarray data, and showed specific upregulation of photoreceptor related genes, such as *Nrl*, *Nr2e3*, *recoverin* and *rhodopsin*; but not genes related to RPCs (e.g. *Sox2* and *Pax6*), RGCs (e.g., *Ngn2, Math5, Brn3a,* and *Tuj1*) and other retinal cell types (e.g. *PKCα* and *CRALBP*) ([Fig. 3c,d](#f3){ref-type="fig"}). Along with photoreceptor degeneration in the KO retina at 1 M, the levels of expression of photoreceptor related genes were also downregulated while the expression of other non-photoreceptor-related genes remained unchanged (not shown). Despite the upregulation of *Lin28b* and *Eya2* -- markers of RPCs for early born neurons (e.g. RGCs) -- no significant changes in numbers of RGCs or levels of expression of RGC related genes were noted in the postnatal retinae of KO mice. The increase of photoreceptor specific protein expression in KO mice was consistent with the previous report[@b14] and was further verified by immunofluorescence labeling. Moderate elevation of Recoverin- and Rhodopsin-immunofluorescence intensities was detected in P3 KO retinae compared to littermate WT controls ([Supplementary Fig. 4](#S1){ref-type="supplementary-material"}). The data suggest selective destabilization of photoreceptor gene expression associated with photoreceptor degeneration in the KO retina.

Targeted deletion of *Ezh2* from RGCs does not affect cell homeostasis or RGC gene expression
---------------------------------------------------------------------------------------------

The finding that RPC inactivation of *Ezh2* induces primarily photoreceptor degeneration and gene expression changes suggests that *Ezh2* selectively regulates photoreceptor related genes. If this hypothesis is true, *Ezh2* deficiency in other retinal cell types should not directly cause retinal neurodegeneration. To test this hypothesis, we conditionally inactivated *Ezh2* from all RGC progenitors, using a *Math5-Cre* driver (*Math5-*KO or *Math5-Cre*^+^; *Ezh2*^*flox/flox*^)[@b20] which mediates gene excision from RPCs that are competent to generate RGCs from E11.5 onward. *Ezh2* expression and *H3K27me3* deposition in the outer neuroblastic layer of *Math5*-KO mice was maintained, but was abolished in the GCL of embryonic and P0 mice, as expected. In *Math5*-KO mice, we observed no RGC loss, nor morphological or functional defects throughout the adulthood ([Fig. 4a--c](#f4){ref-type="fig"}). We next conducted an Affymetrix cDNA microarray analysis to compare gene transcripts in purified RGCs of P0 WT and *Math5*-KO mice. In support of the above findings that deletion of *Ezh2* from intermediate or late stage RPCs selectively impact the expression of photoreceptor related genes, only a few changes were detected when compared to littermate controls (*Ezh2*^*flox/flox*^) ([Fig. 4d](#f4){ref-type="fig"}). Gene Ontology analysis showed no specific association of these gene expression changes with RGCs or RPCs ([Supplementary Fig. 5](#S1){ref-type="supplementary-material"}). Thus, disruption of *Ezh2*-mediated disposition of repressive marks selectively affects the gene expression and homeostasis of photoreceptor cells in the postnatal mouse retina.

Forced expression of *Six1* in the postnatal retina induces photoreceptor degeneration
--------------------------------------------------------------------------------------

*Ezh2* mediates gene repression via catalyzing H3K27me3 on its target genes. We proposed that embryonic loss of *Ezh2* resulted in aberrant sustained expression of its target genes in the postnatal period, which are normally "switched off" during the perinatal period, leading to destabilized photoreceptor gene expression and degeneration throughout the perinatal and postnatal periods. We found that the homeodomain protein *Six1*, which was detected in the embryonic retina, was aberrantly upregulated---from nearly 4 to 20-fold---at E13.5, P0, and 1 M, in KO vs littermate control retinae ([Fig. 5a](#f5){ref-type="fig"}). *Eya2*, a co-factor of *Six1*, followed a similar pattern and was also upregulated at P0 and 1 M of KO retina ([Fig. 5b](#f5){ref-type="fig"}). We next asked if *Ezh2* directly deposited the repressive mark H3K27me3 onto *Six1* by performing chromatin-immunoprecipitation (ChIP) assay with H3K27me3 antibody. *Ezh2* deficiency resulted in *H3K27me3* depletion from the *Six1* and *Nrl* promoters, but not photoreceptor genes, that include *Recoverin*, *Rhodopsin*, and *Nr2e3* ([Fig. 5c--g](#f5){ref-type="fig"}). These results suggest that *Six1*, but not the majority of photoreceptor genes, is a direct target of *Ezh2*. We next performed the ChIP assay to determine if *Six1* binds the core promoters of photoreceptor genes to regulate their expression. We noted that in KO mice, *Six1* occupancy was differentially enriched at the *Recoverin*, *Rhodopsin, Nrl* and *Nr2e3* promoters compared to controls ([Fig. 5h--k](#f5){ref-type="fig"}), indicating that *Six1* regulates the expression of photoreceptor-specific genes. These results suggest the following: upon loss of *Ezh2* and H3K27me3, aberrantly expressed *Six1*, which binds *Eya2* to mediate transcriptional activation, contributes to abnormally elevated expression of photoreceptor genes at P0, prior to their downregulation following postnatal photoreceptor degeneration.

The *Six* family is comprised of homeodomain-containing DNA-binding proteins which play crucial roles in *Drosophila* and vertebrate eye formation[@b21][@b22]. Association between aberrant *Six1* expression and photoreceptor degeneration has not been studied. We thus asked if upregulated *Six1* and *Eya2* in KO might phenocopy some aspects of photoreceptor degeneration seen in *Ezh2* KO retinae. We electroporated plasmids encoding *Six1, Eya*2 or *GFP* (as a control) into postnatal P0 WT retinae *in vivo*. When analyzed at 1 M, *GFP* was expressed in the ONL, and qRT-PCR confirmed elevated *Six1* and *Eya2* expression, respectively, in electroporated WT retinae ([Fig. 6a--c](#f6){ref-type="fig"}). Dual *Six1*/*Eya2* electroporated retinae showed decreased ONL thickness at 1 M compared to controls (*GFP*), *Six1* or *Eya2* individually transfected groups ([Fig. 6c,d](#f6){ref-type="fig"}). Associated with it, we noted decreased and increased levels of cell proliferation and apoptosis markers, *Ki67, Caspase-3*, respectively, in *Six1*/*Eya2*-electroporated group as compared to *GFP, Six1, or Eya2* individually-electroporated groups ([Supplementary Fig. 6](#S1){ref-type="supplementary-material"}). Similar to *Ezh2* KO mice, *recoverin*, *rhodopsin*, *Nrl* and *Nr2e3* were up-regulated in *Six1/Eya2*-co-electroporated retinae at P7 as compared to control *GFP-*electroporated retinae ([Fig. 6e](#f6){ref-type="fig"}), but they were down-regulated in the *Six1/Eya2* co-transfected group retina at P28 due to photoreceptor degeneration ([Fig. 6f](#f6){ref-type="fig"}). The levels of *recoverin*, *rhodopsin*, *Nrl* and *Nr2e3* in *Six1* or *Eya2* individually transfected groups remained unchanged in both time points measured when were compared to control *GFP-*electroporated retinae. The data further support that *Six1*, which requires the presence of *Eya2,* directly mediates the expression of photoreceptor-related genes. Together, our data suggests that adult photoreceptor degeneration secondary to *Ezh2* inactivation during retinal development is mediated by aberrant expression of derepressed *Six1* and *Eya2*, which induces degeneration through decreased cell proliferation and increased apoptosis.

Discussion
==========

We have identified an epigenetic mechanism by which *Ezh2* expression during embryonic and early postnatal retinal development regulates photoreceptor homeostasis in the adult, a stage when *Ezh2* is not normally expressed. In the absence of *Ezh2*, *Six1* is aberrantly upregulated by *Ezh2*-mediated loss of H3K27me3 at its promoter. This causes misexpression of photoreceptor related genes that is, at least in part, contributing to progressive photoreceptor degeneration in this model. Our findings relate transiently expressed, developmental regulators to adult retinal neuron survival and function, and for the first time reveal an epigenetic link by which *in utero* events lead to juvenile and adult-onset vision loss.

Here we uncovered that, in addition to its role in stem cell self-renewal and lineage specification in development[@b23], *Ezh2*-mediated gene repression orchestrates postnatal retinal neuron survival and function. During retinal development, a delicate balance between proliferation and differentiation of progenitors is essential for ensuring proper cell fate development and establishment of cell survival and function. Our data suggests that *Ezh2* governs this process through deposition of repressive modification H3K27me3 on early transcription factors, such as *Six1*, to allow stabilized expression of photoreceptor-related genes in the differentiated cell decedents[@b24]. The *Six* family of homeodomain-contain DNA-binding proteins is a group of transcription factors, which participate in eye formation during early development[@b25]. *Six1* acts together with its coactivators *Eya1* and *Eya2* to drive cell proliferation, tissue growth and cell fate specification in early and mid-eye development in *Drosophila*[@b26]. Yet, its involvement in mammalian retinal development has not been documented. Our results suggest that *Six1* is transiently expressed in the embryonic mouse retina and binds to the promoter regions of photoreceptor specific genes, including *rhodopsin* and *recoverin*, to mediate their levels of expression before birth. Overexpression of *Six1* in the postnatal stage results in destabilized photoreceptor gene expression in the mature retina and causes postnatal onset of retinal degeneration. These findings indicate that epigenetic dysregulation in retinal development is a predisposing factor for congenital photoreceptor dystrophy and postnatal photoreceptor degeneration. Future study investigating photoreceptor rescue in KO mice by deletion of *Six1* or *Eya2* (through crossing with *Six1* or *Eya2* deficient mice) may provide direct testimony if derepression of *Six1* is essential for photoreceptor degeneration following *Ezh2* loss-of-function.

Our findings suggest a previously unappreciated role of *Ezh2* in retinal homeostasis. Report by Aldiri *et al*.[@b27] showed that in *Xenopus*, knockdown of *Ezh2* constrains the generation of retinal neurons and promotes a Müller glial cell fate, partially due to upregulation of Cdk inhibitor p15. In agreement with this finding, Iida *et al*.[@b13] reported accelerated differentiation of Müller glia and rod photoreceptors, and impaired cell proliferation in *Dkk3-Cre* driven *Ezh2* deficient retinae. Using *Pax6*-α*Cre*, Zhang *et al*.[@b14] observed similarly reduced proliferation of RPCs and diminished numbers of retinal ganglion cells and amacrine cells, which is accompanied by increased photoreceptor and Müller cell differentiation, following *Ezh2* deletion. Their RT-PCR and RNA sequencing results from the *Ezh2*-deficient retina revealed drastically upregulated *Six1*, in addition to other genes regulating early RPC development. Nevertheless, the developmental defects in their retinae prevented further elucidation of a role for *Ezh2* in retinal homeostasis. The difference between the phenotypes observed in the present study and those reported by others is presumably due to the fact that *Pax6*-α *Cre*[@b28] and *Dkk3-Cre*[@b12] induce Cre recombinase in early proliferating RPCs before E10.5; whereas, *Chx10-Cre* drives Cre expression in RPCs at a differentiation stage slightly later than that by *Pax6*-α *Cre* and *Dkk3-Cre*[@b16]. Thus, *Ezh2* deletion driven by *Chx10-Cre* results in gene expression changes that occur likely at the nexus point of cell proliferation and differentiation, persisting into adulthood, and lead to postnatal retinal degeneration.

It is intriguing that although highly expressed in RPCs and RGCs during perinatal period, *Ezh2* loss in all retinal progenitors (by use of the *Chx10-Cre* strain) selectively affects gene expression and homeostasis of photoreceptors, but not RGCs or other retinal cell types. This result is further confirmed by using *Math5-Cre*, which drives gene deletion from RPCs that are competent to generate RGCs[@b20]. The data reveal a unique and cell type specific regulation of gene expression by *Ezh2*, rather than genome-wide repression. While its underlying mechanisms remain uncertain, in part, this is unlikely to be caused solely by the spatiotemporal dynamics and cooperative functionalities of other HMTs and demethylases. Among the two HMTs that regulate H3K27 trimethylation, *Ezh1* and *Ezh2*, and the demethylase *Jmjd3*, *Ezh2* and *Jmjd3* are widely expressed in retinal progenitors during development; *Ezh1* is expressed only weakly in the postnatal retina[@b29]. The transient expression of *Ezh2* during development, which is completely repressed postnatally in the retina, was also confirmed during human retinal development[@b11]. A cell type specific effect was also observed with *Jmjd3* deficiency, which resulted in impaired differentiation of subsets of bipolar cells, despite strong *Jmjd3* expression in the RGCs[@b9]. Previous studies have reported a model of bidirectional and mutually reinforcing crosstalk between *Ezh2* and another repressive HMT, *G9a*, on histone hypermethylation in other tissues[@b30][@b31]. In support of a possible crosstalk between these two epigenetic silencing regulators in RGCs, *G9a* (which catalyzes H3K9me2, another repressive histone mark) is highly expressed in RGCs of the mouse retina during a similar period when *Ezh2* is detected[@b10]. It would be interesting to investigate the possible interactions of these repressive epigenetic modifications in RGCs such as by analyzing conditional knockouts of both *G9a* and *Ezh2* in the future.

In summary, our observations point to a central role for *Ezh2*-mediated histone methylation in the epigenetic repression of *Six1* and photoreceptor homeostasis in the adult. *Six1* and the targetable HMT epigenetic enzyme regulating *Six1, Ezh2,* thus may represent novel therapeutic targets in congenital photoreceptor degeneration.

Methods
=======

Generation and genotyping of KO mice
------------------------------------

All animal procedures were performed in accordance with the statement of the Association for Research in Vision and Ophthalmology, and the protocols were approved by Institutional Animal Care Committee (IACUC) of the Schepens Eye Research Institute. Mice were housed in a temperature- controlled room with a 12 h light/dark cycle. Fresh water and rodent diet were available at all times.

Mice carrying deletion of *Ezh2* specifically in all retinal progenitors was produced using the *Chx10-Cre* mice line (from the Jackson Laboratory) crossed with conditional allele of *Ezh2*^*flox/flox*^ mice (from the Mutant Mouse Regional Resource Centers (MMRRC) (<https://www.mmrrc.org/catalog/sds.php?mmrrc_id=15499>). *Chx10-cre; Ezh2*^*flox/flox*^ (KO) mice were eventually generated and allowed to investigate its function in retina development.

Mice were genotyped by PCR analysis. Mice were anesthetized with 2--4% isoflurane (Vedco Inc., MO, USA) and less than 0.5 cm of tail tissues were cut by razor blade. The tail tissue was incubated in direct PCR buffer solution (Viagen Biotech, CA, USA) containing proteinase K (Invitrogen Life Technologies, Carlsbad, CA, USA), and 56 °C overnight according to the manufacturer's instruction. PCR genotyping was performed using the following primers: *Chx10-cre* forward primer 5′-GGGCACCTGGGACCAACTTCACGA-3′ and reverse primer 5′-CGGCGGCGGTCACGAACTCC-3′ (750 bp PCR product)[@b16]; *Ezh2* forward primer 5′-CTGCTCTGAATGGCAACTCC-3′ and reverse primer 5′-TTATTCATAGAGCCACCTGG-3′ (Control 430 bp and KO 470 bp). The PCR was performed using Apex Taq DNA Polymerase (Genesse Scientific, San Diego, CA). The primers were designed to detect the expression of *Ezh2* gene at P0 and 1 M. The primers information as follows: forward primer 5′-TCAGGATGAAGCAGACAGAAG-3′ and reverse primer 5′-TTTGTTGCCCTTTCGGGTTG-3′. The PCR reaction was carried out according to the manufacturer's instruction.

Hematoxylin and Eosin (HE) Staining and Immunohistochemistry (IHC)
------------------------------------------------------------------

Fixation, sectioning, HE staining were carried out as described[@b32]. For immunohistochemistry, mouse embryos and eyecups were fixed in 4% paraformaldehyde in PBS for either 30 min to 3 h. The samples were cryoprotected, embedded, frozen, and sectioned (8 μm thick). Slides were incubated with blocking solution (4% normal donkey serum and 0.5% Triton X-100 in PBS) for 1 h, and then with the primary antibodies overnight at 4 °C degree. Slides were washed with PBS three times for 10 min each time and incubated with the secondary antibodies for 1 h at room temperature. The specimens were observed under a laser confocal microscope (Leica TCS SP5).

Primary antibodies used in this study were *Beta-III Tubulin* (1:1000; AB9354, Millpore), *Recoverin* Antibody (1:1000; AB5585, Millpore), *PNA* Antibody (1:200; Sigma), *Ezh2* (1:1000; 3147s, cell signaling) and *H3K27me3* (1:500, 9733S, Cell Signaling). Second antibodies were *Cy3*-labeled donkey anti-mouse antibody (1:1500; Vector Laboratories), *Cy3*-labeled donkey anti-rabbit antibody (1:1500; Vector Laboratories) and Alexa Fluor 488 Conjugated antibody (1:400; cell signaling). For all quantifications, KO mice and controls were used for all analyses. Quantification of the thickness of nuclear staining for each antibody was carried out on fluorescence microscope images (Leica, Mannheim, Germany) with ImageJ software (National Institutes of Health, Bethesda, MD). Student's *t* tests were used to measure differences between KO mice and controls.

Transmission Electron Microscopy (TEM)
--------------------------------------

Mice were euthanized with CO~2~ and the eyes were enucleated and the posterior segments fixed in 1% glutaraldehyde/1% paraformaldehyde in PBS and postfixed in veronal acetate buffered osmium tetroxide (2%), dehydrated in ethanol and water, and embedded in Epon. Ultrathin sections were cut from blocks and mounted on copper grids. The specimens were examined by using a transmission electron microscope (Tecnai Spirit, FEI).

Optical Coherence Tomography (OCT)
----------------------------------

Retinal morphology and thickness of the ONL of live mice were assessed non-invasively with spectrum domain optical coherence tomography (SD-OCT). Mice were anesthetized with an intraperitoneal injection of ketamine (120 mg/kg)/xylazine (12 mg/kg) mixture and pupils were dilated using tropicamide (1%; Falcon Pharmaceuticals, Fort Worth, TX). Lubricant gel drops (Novartis Pharmaceuticals Corp, East Hanover, NJ) were applied to maintain the moisture of cornea. Images were acquired using SD-OCT (Bioptigen Inc, Research Triangle Park, NC). Radial volume scan (centered on optic disc, diameter 1.3 mm) was used, and ONL thickness within the 200--400 μm area from the central of optic disk were measured and analyzed for the ONL thickness as previously described[@b33].

Electroretinogram (ERG)
-----------------------

Retinal functions of control and KO mice were assessed by ERG. Mice were dark-adapted 5 h, and then anesthetized with intraperitoneal injection. Pupils were dilated with topical 1% tropicamide and 0.5% phenylephrine HCl, and the mice were placed on a heating pad for the duration of the ERG recordings. The mice were stimulated with stroboscopic stimuli with six levels of stimuli 0.00022, 0.00215, 0.06455, 0.64545, 2.15 and 500 cd-s/m^2^ to elicit the scotopic ERGs. After the scotopic measurement, mice were exposed to a rod-saturating background light (40 cd/m^2^) for 10 min, then the mice with stimuli 10 cd-s/m^2^ for the photopic ERGs. The data were recorded and processed by the ERG system (Espion Electroretinography System; Diagnosys LLC, Lowell, MA). The amplitudes of a-wave and b-wave of ERG response were determined.

Microarray Expression Analysis
------------------------------

Total RNA was extracted from both cortices from three KO mice and controls at P0 stage. Total retinal RNA (5 μg) was isolated using RNeasy Plus Mini Kit (QIAGEN, Valencia, CA, USA) and converted to cDNA using the One-Cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA, USA) according to the manufacturer's instructions. Gene Expression of KO mice and controls were detected using the Affymetrix Mouse Gene 1.0 ST Array (Dana-Farber Cancer Institute) and the microarray data were analyzed using the dChip software ([www.dchip.org](http://www.dchip.org)). Gene Ontology (GO) analysis of genes up-regulated and down-regulated in the KO mice retina was performed using DAVID tools (<http://david.abcc.ncifcrf.gov>).

Quantitative Real-Time PCR (qPCR)
---------------------------------

Total retina RNA was extracted using RNeasy Plus Mini Kit (QIAGEN, Valencia, CA, USA) and cDNA synthase using SuperScript™ III First-Strand Synthesis System (Invitrogen Life Technologies, Carlsbad, CA, USA). QPCR was performed using SYBR FAST qPCR Kits (Kapa Biosystems, Woburn, MA, USA) and LightCycler^®^ 480 (Roche Biosystems; Indianapolis, IN) according to the manufacturer's instructions. The primer sequences are listed in [Supplementary Table 1](#S1){ref-type="supplementary-material"}. For relative comparison of each gene, we analyzed the *Ct* value of real-time PCR data with the ∆∆Ct method normalizing by an endogenous control (glyceraldehyde 3-phosphate dehydrogenase, *GAPDH*).

Chromatin immunoprecipitation (ChIP)
------------------------------------

The P0 retina tissues of KO mice and controls were cut into small pieces (between 1--3 mm^3^) and the tissues were cross-linked with 1% paraformaldehyde (\#252549, Sigma) in PBS for 1 hour at 37 °C. Then chromatin isolation and ChIP assay were performed according to the manufacturer's protocol using a commercially available kit (EZ-Zyme Chromatin prep kit, EZ-ChIP; Millipore). The immunoprecipitated chromatin DNA was incubated with rabbit anti-*H3K27me3* antibody (\#9756s, Cell Signaling) and goat anti-*six1* antibody (Santa Cruz) and was analyzed by qPCR using gene-specific primers ([Supplementary Table 1](#S1){ref-type="supplementary-material"}).

RGC qualification
-----------------

The mouse retinas were dissected to remove the cornea, lens, iris, sclera, and choroid. The vitreous was carefully removed and the flat mounted retina was placed on the super-frost sections with ganglion cell layer facing up. RGCs were double immunolabeled with *β-III tubulin* (Tuj1) and DAPI. Our previous studies showed that Tuj1 specifically labels RGCs in retinal flat-mounts[@b34]. The specimens were visualized under the confocal microscope at 800× magnification. The flat mounts were divided into quadrants: superior, temporal, nasal and inferior and total 16 square regions of each eye were photographed and all *β-III tubulin* positive cells in the GCL were quantified. The average RGC densities of the whole retina were calculated and the percentage of RGC loss was determined by comparing RGC densities with that obtained from the contralateral control eyes.

*In vivo* Electroporation
-------------------------

Three of the expression vectors were purchased from GeneCopoeia (Germantown, MD, USA), including *pEZ-M90* (*GFP* report), *pEZ-M90-Six1* and *pEZ-M90-Eya2*. The experiment was divided into four groups: *pEZ-M90* (*GFP* group), *pEZ-M90-Six1* (*Six1* group), *pEZ-M90-Eya2* (*Ezh2* group), and *pEZ-M90-Six1* mixed with *pEZ-M90-Eya2* (*Six1/Ezh2* group). The plasmids were amplified using QIAGEN Plasmid Maxi Kit (Valencia, CA, USA). Newborn ICR mouse pups were anesthetized by chilling on ice, and a small incision was made in the eyelid and sclera near the lens with a 32-gauge needle. 0.5--1 μl DNA solutions (1 μg/μl) in PBS containing 0.1% blue dye as a tracer were injected into the subretinal space through the incision by using a Hamilton syringe (Reno, Nevada, USA) with a 32 gauge blunt-ended needle under a dissecting microscope. After DNA injection, 10 mm diameter tweezer-type electrodes (Nepagene, Chiba, Japan) briefly soaked in PBS were placed to softly hold the heads of the pups. Five square pulses of 80 volts and 50 ms duration with 950 ms intervals were applied by using a NEPA21 Electroporator (Nepagene, Chiba, Japan).

The eyeballs were harvested at 7 and 28 days, respectively, after electroporation. The eyeballs were fixed with 4% paraformaldehyde, cryoprotected with 30% sucrose, embedded in OCT compound (Sakura Finetek, Tokyo, Japan) and cryosectioned into 8 μm section. The *GFP*-positive retina sections were selected under a Leica DM3000 fluorescent microscope. Only retinal sections containing 1/3 or more GFP expressing cells were selected for scoring. Mouse eyes that developed cataract, small eyes, or apparent inflammation were excluded. For each group, at least 12 *GFP-*positive retinae were scored. Quantification of the thickness of ONL for each group was carried out on fluorescence microscope images with NIH ImageJ software. At 7 and 28 days after electroporation, electroporated retinae were dissected under a fluorescent microscope to select the *GFP*-positive retinae. Total retina RNA was extracted and cDNA was synthesized. QPCR was performed and the results were analyzed with the ∆Ct method.

Statistical Analysis
--------------------

The statistical significance of IHC, OCT, ERG and qPCR results were analyzed by using using GraphPad Prism 5 statistical software (GraphPad Software, La Jolla, CA). All the numerical variables in this article were presented as Mean ± S.E.M. Two-tailed student's *t*-test was used on numerical variables of independent samples; one-way ANOVA analysis was applied for comparisons of data among groups.
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![*Ezh2* deletion induces progressive retinal degeneration.\
(**a**) Intron/exon diagram of mice *Ezh2* and *Ezh2*^*flox/flox*^ alleles. (**b**) Genotyping of *Ezh2* and *Chx10-cre* genes. (**c,d**) Immunohistochemistry (**c**) and qPCR (**d**) assessment of *Ezh2* expression in the retinas of control and KO mice: note that *Ezh2* expression was detected in the P0 control retina, but was lost in the adult retina. (**e**) Retinal sections labeled for nuclear marker DAPI (blue) and photoreceptor cell marker anti-Recoverin (red). (**f**) Retinal thickness measured in P0 retinal sections. (**g**) Quantification of ONL thickness in retinal sections of mice at different ages, showing progressive ONL degeneration from 1 M to 1 Y in the KO mouse retina. Bars represent the mean ± S.D. of at least six biological replicates. NS indicates no significant difference; \*\*indicates P \< 0.01; \*\*\*indicates P \< 0.001.](srep33887-f1){#f1}

![*Ezh2* deletion impairs postnatal photoreceptor cell function.\
(**a**) Representative ERG waveforms of control and KO mice that were subjected to flashes of increasing intensities under scotopic conditions, which isolate rod photoreceptor-mediated responses. (**b--e**) The amplitudes of scotopic ERG a- and b-waves, which measures cone responses: Black bar, WT controls; white bar, KO. Note the abnormal and progressive reduction of ERG a- and b-wave amplitudes in KO mice from 1 M to 1 Y. Data represent the mean ± S.D. of at least six biological replicates. NS indicates no significant difference; \*indicates P \< 0.05; \*\*indicates P \< 0.01; \*\*\*indicates P \< 0.001.](srep33887-f2){#f2}

![*Ezh2* deletion promotes derepression of *Six1* and photoreceptor-related genes.\
(**a**) Heat map of clustered microarray data from P0 retina showed 132 genes changed \>1.5 fold between control and KO mice. (**b**) GO analysis of functional categories identified a high number of genes that are directly involved in photoreceptor development, differentiation and photosensitivity. (**c,d**) qPCR results from P0 WT and KO retina showed the relative expression of retinal progenitor cell (RPC) and neuron-related genes in KO mice at P0. RGCs, retinal ganglion cells; MC, Müller cells. Note the significant elevation of *Six1*, *Eya2* and rod photoreceptor-related gene expression, including *Nr2e3*, *Recoverin* (Rcvrn), *Nrl* and *Rhodopsin* (Rho), in KO mice. Bars represent the mean ± S.D. of at least six biological replicates. NS indicates no significant difference; \*indicates P \< 0.05; \*\*indicates P \< 0.01; \*\*\*indicates P \< 0.001.](srep33887-f3){#f3}

![RGC-specific *Ezh2* inactivation reduces *H3K27me3* deposition and gene expression of selective transcripts.\
(**a**) Absence of H3K27me3 deposition (green) and *Ezh2* expression (red) in the GCL of P0 *Math5-KO* retina compared to P0 control (*Ezh2*^*flox/flox*^) mouse retina. (**b,c**) Assessment of RGC (red) morphology (**b**) and cell counts (**c**) in Tuj1-immunolabeled retinal flat-mounts of adult control Black bar: WT controls; white bar: Math5-KO. (*Ezh2*^*flox/flox*^) and *Math5-KO* mice showed no significant differences in RGC morphology or cell number. (**d**) Heat map of microarray analysis using RNAs collected from RGCs purified in P0 *Math5-KO* and littermate controls. One gene was up-regulated and 18 genes were down-regulated over 1.5 fold in *Math5-KO* mice compared to control mice. Bars represent the mean ± S.D. of at least six biological replicates.](srep33887-f4){#f4}

![*Ezh2* deficiency causes derepression of *Six1* and dysregulation of photoreceptor gene expression in the postnatal retina.\
(**a,b**) qPCR results showed aberrantly increased expression of *Six1* and *Eya2* genes in the postnatal retina of KO mice. (**c--g**) DNA ChIP analysis showed significant reductions of *Ezh2* binding to *Six1* and *Nrl* promoters, but not to *Recoverin*, *Rhodopsin* or *Nr2e3* promoters, in P0 KO retinas compared to littermate control retinas, suggesting that *Ezh2* directly targets *Six1* and *Nrl.* (**h--k**) KO retinae exhibited significantly increased enrichment of *Six1* binding to the promoters of photoreceptor-related genes, *Recoverin (Rcvrn)*, *Rhodopsin (Rho)*, *Nrl* and *Nr2e3* genes. Bars represent the mean ± S.D. of at least six biological replicates. NS indicates no significant difference; \*\*indicates P \< 0.01.](srep33887-f5){#f5}

![Forced expression of *Six1* and *Eya2* in postnatal retina induces photoreceptor degeneration.\
(**a,b**) qPCR analyses of *Six1* (**a**) and *Eya2* (**b**) mRNA levels in wild-type mouse retinae taken at P7 and P28 following P0 *in vivo* electroporation of *Six1*, *Eya2*, or *Six1* and *Eya2* simultaneously (*Six1/Eya2*) to the mouse retinae (n = 12/group). (**c**) Detection of *GFP* expression in 1 M mouse retinal sections after P0 *in vivo* electroporation of *GFP*, *Six1*, *Eya2*, or *Six1* and *Eya2* simultaneously. Note the robust detection of *GFP* expression in the ONL and the thinner ONL in *Six1/Eya2* electroporated retina compared to the other electroporated retina groups. Vertical lines mark the range of the ONL. (**d**) Quantification of ONL thicknesses in retinal sections of 1 M old mice that received *in vivo* electroporation of *GFP*, *Six1*, *Eya2*, or *Six1* and *Eya2* simultaneously at P0. (**e,f**) Results of qPCR showed increased mRNA levels of photoreceptor genes only in *Six1* and *Eya2* co-electroporated retinas at P7 (**e**) but reduced mRNA levels of photoreceptor genes at P28, when compared to the *GFP*-electroporated group. Bars represent the mean ± S.D. of at least six biological replicates. \*Indicates *P* \< 0.05, \*\* indicates *P* \< 0.01.](srep33887-f6){#f6}

###### Representative up and down-regulated genes in Chx10-cre Ezh2^*flox/flox*^ mice P0 retina from microarray hybridization.

  -------------------- ------------- ---------------------------------------------------------------------------------------------- --------
  NM_175540                Eda2r                                   ectodysplasin A2 isoform receptor                                  3.95
  NM_009189                Six1                           sine oculis-related homeobox 1 homolog (Drosophila)                         3.83
  NM_009849               Entpd2                            ectonucleoside triphosphate diphosphohydrolase 2                          3.19
  NM_008992                Abcd4                           ATP-binding cassette, sub-family D (ALD), member 4                         2.93
  NM_007723                Cnga1                                cyclic nucleotide gated channel alpha 1                               2.41
  NM_028864               Zc3hav1                                  zinc finger CCCH type, antiviral 1                                 2.32
  NM_013750               Phlda3                          pleckstrin homology-like domain, family A, member 3                         2.31
  NM_030707                Fcrls                                 Fc receptor-like S, scavenger receptor                               2.3
  NM_013708                Nr2e3                            nuclear receptor subfamily 2, group E, member 3                           2.29
  NM_023048                Asb4                                 ankyrin repeat and SOCS box-containing 4                              2.27
  NM_182993               Slc17a7       solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7       2.25
  NM_145383                 Rho                                                rhodopsin                                              2.23
  NM_011978               Slc27a2                     solute carrier family 27 (fatty acid transporter), member 2                     2.2
  NM_009038                Rcvrn                                               recoverin                                              2.19
  NM_009022               Aldh1a2                            aldehyde dehydrogenase family 1, subfamily A2                            2.18
  NM_008806                Pde6b                       phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide                     2.1
  BC086653                 Lba1                                          lupus brain antigen 1                                         2
  NM_010720                Lipg                                           lipase, endothelial                                         1.89
  NM_010165                Eya2                                    eyes absent 2 homolog (Drosophila)                                 1.88
  NM_011851                Nt5e                                          5′ nucleotidase, ecto                                        1.88
  NM_001031772            Lin28b                                     lin-28 homolog B (C. elegans)                                    1.85
  NM_023456                 Npy                                              neuropeptide Y                                           1.85
  NM_008630                 Mt2                                            metallothionein 2                                          1.82
  NM_007669               Cdkn1a                               cyclin-dependent kinase inhibitor 1A (P21)                             1.81
  NM_133982                Rpp25                                   ribonuclease P 25 subunit (human)                                  1.79
  NM_176844               Chrna5                          cholinergic receptor, nicotinic, alpha polypeptide 5                        1.78
  NM_008736                 Nrl                                    neural retina leucine zipper gene                                  1.78
  NM_028713                Rftn2                                        raftlin family member 2                                       1.76
  NM_013602                 Mt1                                            metallothionein 1                                          1.73
  NM_001033167           Slc22a23                                 solute carrier family 22, member 23                                 1.73
  NM_001128103             Ano3                                               anoctamin 3                                             1.72
  NM_031257               Plekha2     pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2    1.7
  NM_009573                Zic1                                 zinc finger protein of the cerebellum 1                               1.7
  NM_008532               Tacstd1                             tumor-associated calcium signal transducer 1                            1.66
  NM_178254                Tcfl5                          transcription factor-like 5 (basic helix-loop-helix)                        1.66
  NM_013454                Abca1                          ATP-binding cassette, sub-family A (ABC1), member 1                         1.64
  NM_019397                Egfl6                                      EGF-like-domain, multiple 6                                     1.63
  NM_027871               Arhgef3                            Rho guanine nucleotide exchange factor (GEF) 3                           1.62
  NM_172119                Dio3                                    deiodinase, iodothyronine type III                                 1.62
  NM_019413                Robo1                                   roundabout homolog 1 (Drosophila)                                  1.58
  NM_153546               Mboat1                          membrane bound O-acyltransferase domain containing 1                       −1.57
  NM_009657                Aldoc                                   aldolase C, fructose-bisphosphate                                 −1.62
  NM_172880              Tmprss11e                                 transmembrane protease, serine 11e                                −1.65
  NM_008397                Itga6                                            integrin alpha 6                                         −1.66
  NM_009528                Wnt7b                               wingless-related MMTV integration site 7B                             −1.66
  NM_033268                Actn2                                            actinin alpha 2                                          −1.68
  NM_025681                Lix1                                   limb expression 1 homolog (chicken)                                −1.69
  NM_007515               Slc7a3             solute carrier family 7 (cationic amino acid transporter, y+ system), member 3           −1.7
  NM_015800                Crim1                       cysteine rich transmembrane BMP regulator 1 (chordin like)                    −1.71
  NM_001113331             Shc1                         src homology 2 domain-containing transforming protein C1                     −1.77
  NM_011990               Slc7a11           solute carrier family 7 (cationic amino acid transporter, y+ system), member 11          −1.77
  NM_011419               Jarid1d                          jumonji, AT rich interactive domain 1D (Rbp2 like)                        −1.79
  NM_173379               Leprel1                                           leprecan-like 1                                          −1.81
  NM_009932               Col4a2                                       collagen, type IV, alpha 2                                    −1.82
  NM_001035533             Akap2                                    A kinase (PRKA) anchor protein 2                                 −1.83
  NM_012008                Ddx3y                           DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked                        −1.84
  NM_009527                Wnt7a                               wingless-related MMTV integration site 7A                             −1.84
  NM_027934               Rnf180                                        ring finger protein 180                                      −1.88
  NM_013737               Pla2g7            phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)         −1.89
  NM_007514               Slc7a2             solute carrier family 7 (cationic amino acid transporter, y+ system), member 2          −1.89
  NM_009484                 Uty                   ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome                −1.9
  NM_012011               Eif2s3y           eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked          −1.95
  NM_025760               Ptplad2                       protein tyrosine phosphatase-like A domain containing 2                      −1.97
  NM_172838              Slc16a12                solute carrier family 16 (monocarboxylic acid transporters), member 12              −1.97
  NM_009848               Entpd1                            ectonucleoside triphosphate diphosphohydrolase 1                         −2.03
  NM_007933                Eno3                                          enolase 3, beta muscle                                      −2.05
  NM_026878               Rasl11b                                    RAS-like, family 11, member B                                   −2.11
  NM_025769               Efcab1                                    EF hand calcium binding domain 1                                 −2.18
  NM_146120                 Gsn                                                 gelsolin                                             −2.23
  NM_198191               Pip5kl1                           phosphatidylinositol-4-phosphate 5-kinase-like 1                         −2.24
  NM_026056                Cap2                           CAP, adenylate cyclase-associated protein, 2 (yeast)                       −2.25
  NM_172868                Palm2                                              paralemmin 2                                           −2.25
  NM_007773               Crybb2                                          crystallin, beta B2                                        −2.26
  NM_011939                Hsf4                                    heat shock transcription factor 4                                 −2.28
  NM_172152               Slc24a4               solute carrier family 24 (sodium/potassium/calcium exchanger), member 4               −2.3
  NM_144945                Lgi2                                 leucine-rich repeat LGI family, member 2                             −2.34
  ENSMUST00000108875       Birc7                              baculoviral IAP repeat-containing 7 (livin)                            −2.35
  NM_177780                Dock5                                       dedicator of cytokinesis 5                                    −2.38
  NM_008180                 Gss                                          glutathione synthetase                                       −2.4
  NM_008010                Fgfr3                                  fibroblast growth factor receptor 3                                −2.43
  NM_011224                Pygm                                      muscle glycogen phosphorylase                                   −2.43
  NM_025711                Aspn                                                 asporin                                              −2.49
  NM_013822                Jag1                                                 jagged 1                                             −2.68
  NM_146142                Tdrd7                                       tudor domain containing 7                                     −2.73
  NM_030127                Htra3                                        HtrA serine peptidase 3                                      −2.84
  NM_177041                Flad1                     RFad1, flavin adenine dinucleotide synthetase, homolog (yeast)                   −2.9
  NM_181541               Caprin2                                        caprin family member 2                                       −3.1
  NM_001113368            Ceacam2                      carcinoembryonic antigen-related cell adhesion molecule 2                     −3.12
  NM_011325               Scnn1b                                sodium channel, nonvoltage-gated 1 beta                              −3.14
  NM_007776                Crygd                                          crystallin, gamma D                                        −3.19
  NM_026439               Ccdc80                                    coiled-coil domain containing 80                                 −3.34
  NM_138953                Ell2                                  elongation factor RNA polymerase II 2                               −3.34
  XR_032001             Csnk2a1-rs2                           casein kinase 2, alpha 1, related sequence 2                           −3.39
  NM_010442                Hmox1                                      heme oxygenase (decycling) 1                                   −3.68
  NM_028813                 Vit                                                  vitrin                                              −3.74
  NM_001011807            Olfr191                                        olfactory receptor 191                                        −4
  NM_019738                Nupr1                                           nuclear protein 1                                         −4.03
  NM_138683                Rspo1                                   R-spondin homolog (Xenopus laevis)                                −4.23
  NM_008100                 Gcg                                                 glucagon                                             −4.64
  NM_010917                Nid1                                                nidogen 1                                              −4.7
  NM_013501                Cryaa                                          crystallin, alpha A                                        −4.79
  NM_009604                Chrng                           cholinergic receptor, nicotinic, gamma polypeptide                        −5.11
  NM_146405               Olfr228                                        olfactory receptor 228                                       −5.4
  NM_145835                Lctl                                               lactase-like                                           −5.46
  NM_018870                Pgam2                                       phosphoglycerate mutase 2                                     −5.51
  NM_175013                Pgm5                                           phosphoglucomutase 5                                       −5.55
  NM_027010                Crygf                                          crystallin, gamma F                                        −5.58
  NM_144805               Tmem40                                        transmembrane protein 40                                     −5.68
  NM_008048               Igfbp7                              insulin-like growth factor binding protein 7                           −6.14
  NM_020288               Olfr749                                        olfactory receptor 749                                      −6.33
  NM_030022               Grifin                                  galectin-related inter-fiber protein                               −7.11
  NM_023695               Crybb1                                          crystallin, beta B1                                        −7.18
  NM_008760                 Ogn                                               osteoglycin                                            −7.83
  NM_009965               Cryba1                                          crystallin, beta A1                                        −8.96
  NM_007774                Cryga                                          crystallin, gamma A                                        −9.34
  NM_019957               Dnase2b                                      deoxyribonuclease II beta                                     −9.61
  NM_021352               Crybb3                                          crystallin, beta B3                                        −9.66
  NM_007777                Cryge                                          crystallin, gamma E                                        −10.13
  NM_009964                Cryab                                          crystallin, alpha B                                        −11.17
  NM_153076                Crygn                                          crystallin, gamma N                                        −12.64
  NM_007601                Capn3                                               calpain 3                                             −13.48
  NM_144761                Crygb                                          crystallin, gamma B                                        −13.48
  NM_008123                Gja8                                      gap junction protein, alpha 8                                   −14.36
  NM_001002896             Bfsp2                             beaded filament structural protein 2, phakinin                          −15.1
  NM_009751                Bfsp1                           beaded filament structural protein 1, in lens-CP94                        −15.4
  NM_021541               Cryba2                                          crystallin, beta A2                                        −17.03
  NM_016975                Gja3                                      gap junction protein, alpha 3                                   −17.29
  NM_001082573             Crygc                                          crystallin, gamma C                                        −17.63
  NM_021351               Cryba4                                          crystallin, beta A4                                        −21.81
  NM_008600                 Mip                                major intrinsic protein of eye lens fiber                             −21.81
  NM_177693                Lim2                                    lens intrinsic membrane protein 2                                 −23.85
  NM_009967                Crygs                                          crystallin, gamma S                                        −25.42
  -------------------- ------------- ---------------------------------------------------------------------------------------------- --------
